Physician profile
Amy Cox
NPI 1568567527
$1,058.01
in general payments reported to CMS, 2019-2025
17 companies · $374 in 2025
The $374 reported for 2025 was more than what 89% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $22.43 · 2021: $39.50 · 2022: $123 · 2023: $215 · 2024: $283 · 2025: $374.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $873.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $872.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi Pasteur INC. | $149.05 | 2022-2025 | |
| Kowa Pharmaceuticals America, INC. | $141.81 | 2025 | Zoryve |
| Edwards Lifesciences Corporation | $135.94 | 2020-2025 | Inspiris Resilia Aortic Valve, Konect Resilia, Mitris Resilia Mitral Valve |
| Merck Sharp & Dohme LLC | $112.99 | 2022-2025 | Vaxelis, Gardasil 9, Vaxneuvance |
| Alk-Abello, INC | $74.79 | 2024-2025 | Neffy, Ragwitek, Grastek |
| Sanofi-Aventis U.S. LLC | $66.93 | 2024 | |
| Verrica Pharmaceuticals INC. | $59.24 | 2023-2024 | Ycanth |
| Cranial Technologies, INC | $49.53 | 2022-2024 | Doc Band |
| Takeda Pharmaceuticals U.S.A., INC. | $48.30 | 2023 | |
| Hologic Sales and Service, LLC | $48.20 | 2022-2023 | Aptima |
| Pfizer INC. | $43.68 | 2022-2024 | |
| Ars Pharmaceuticals Operations, INC. | $27.62 | 2025 | Neffy |
| Tris Pharma INC | $24.20 | 2023 | Dyanavel Xr |
| Corium, LLC | $21.53 | 2024 | Azstarys |
| Cognoa, INC. | $21.13 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ultragenyx Pharmaceutical INC. | $19.61 | 2022 | |
| Kaleo, INC. | $13.46 | 2023 | Auvi-Q |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Cox listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.